OBJECTIVES Immune activation, among other driven by IFN-α and -γ activation is a main feature of progressive HIV infection. Suppressor of cytokine signaling (SOCS) 1 and 3 are negative feedback regulators of the IFN-α and -γ axis. Here, we analyzed the role of 9 single nucleotide polymorphisms (SNPs) within SOCS-1 and 3 genes for their association with HIV progression rate in a cohort of 318 rapid vs 376 slow progressors from the Swiss HIV Cohort Study. DESIGN AND METHODS: We analyzed 9 SNPs, which we have identified in Swiss blood donors, in a cohort of HIV-infected patients (n=1144), which have been categorized according to the decline in CD4+ T-cell counts. In all the conducted analyses, we focused on the comparison between rapi...
BACKGROUND Kaposi's sarcoma (KS), the most common AIDS related cancer, represents a major public co...
The SDF-1 3'A allelic polymorphism has been reported to influence either positively or negatively th...
Background: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
Objectives: Immune activation, among others driven by interferon (IFN)-α and IFN-γ activation, is a ...
Immune activation, among others driven by interferon (IFN)-α and IFN-γ activation, is a main feature...
© 2016 Vladimir V. Anokhin et al.The genetic background of an individual plays an important role in ...
The genetic background of an individual plays an important role in the progression of HIV infection ...
About 2-5% of HIV-1-infected subjects, defined as long-term non-progressors (LTNPs), remain immunolo...
Aim: To screen the genetic regions of SOCS1 and SOCS3 for variations (mutations and polymorphisms). ...
Background. A mean of 9–10 years of human immunodeficiency virus type 1 (HIV-1) infection elapse bef...
BACKGROUND: The clinical course of HIV-1 infection is highly variable among individuals, at least in...
SummaryObjectivesAbout 2–5% of HIV-1-infected subjects, defined as long-term non-progressors (LTNPs)...
Background. Host genetic variation influences human immunodeficiency virus (HIV) infection and progr...
BACKGROUND: Metabolic complications, including cardiovascular events and diabetes mellitus (DM), are...
Background.Metabolic complications, including cardiovascular events and diabetes mellitus (DM), are ...
BACKGROUND Kaposi's sarcoma (KS), the most common AIDS related cancer, represents a major public co...
The SDF-1 3'A allelic polymorphism has been reported to influence either positively or negatively th...
Background: Various patterns of HIV-1 disease progression are described in clinical practice and in ...
Objectives: Immune activation, among others driven by interferon (IFN)-α and IFN-γ activation, is a ...
Immune activation, among others driven by interferon (IFN)-α and IFN-γ activation, is a main feature...
© 2016 Vladimir V. Anokhin et al.The genetic background of an individual plays an important role in ...
The genetic background of an individual plays an important role in the progression of HIV infection ...
About 2-5% of HIV-1-infected subjects, defined as long-term non-progressors (LTNPs), remain immunolo...
Aim: To screen the genetic regions of SOCS1 and SOCS3 for variations (mutations and polymorphisms). ...
Background. A mean of 9–10 years of human immunodeficiency virus type 1 (HIV-1) infection elapse bef...
BACKGROUND: The clinical course of HIV-1 infection is highly variable among individuals, at least in...
SummaryObjectivesAbout 2–5% of HIV-1-infected subjects, defined as long-term non-progressors (LTNPs)...
Background. Host genetic variation influences human immunodeficiency virus (HIV) infection and progr...
BACKGROUND: Metabolic complications, including cardiovascular events and diabetes mellitus (DM), are...
Background.Metabolic complications, including cardiovascular events and diabetes mellitus (DM), are ...
BACKGROUND Kaposi's sarcoma (KS), the most common AIDS related cancer, represents a major public co...
The SDF-1 3'A allelic polymorphism has been reported to influence either positively or negatively th...
Background: Various patterns of HIV-1 disease progression are described in clinical practice and in ...